The potential impact of sickness-motivated behavior on the expression of neuropsychiatric disturbances in systemic lupus erythematosus

Medical Hypotheses

Volumn 69, Issue 3, 2007, Pages 502-507

  Santoro, Thomas J ^a   Tomita, Michiyo ^b   Larson, Susan J ^c  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UND School of Medicine & Health Sciences Southeast Campus   (United States)

^c Université du Québec à Montréal   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ARTICLE; AUTOIMMUNE DISEASE; COGNITION; EMOTIONALITY; FEEDING BEHAVIOR; ILLNESS BEHAVIOR; IMMUNE SYSTEM; LIBIDO; MENTAL DISEASE; MOTIVATION; NONHUMAN; PRIORITY JOURNAL; SLEEP PATTERN; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; AUTOIMMUNITY; BEHAVIOR; COGNITION; CYTOKINES; HUMANS; IMMUNE SYSTEM; LUPUS ERYTHEMATOSUS, SYSTEMIC; MENTAL DISORDERS; MODELS, BIOLOGICAL; MODELS, THEORETICAL; NERVOUS SYSTEM DISEASES; PROGNOSIS; TREATMENT OUTCOME;

MUS;

EID: 34447251660     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.01.033     Document Type: Article

References (57)

1. Dantzer R. Cytokine-induced sickness behavior: Where do we stand?. Brain Behav Immun 15 (2001) 7-24
2. Bret-Dibat J.L., Bluthe R.M., Kent S., Kelley K.W., and Dantzer R. Lipopolysaccharide and interleukin-1 depress food-motivated behavior in mice by a vagal-mediated mechanism. Brain Behav Immun 9 (1995) 242-246
3. Kimura M., Majde J.A., Toth L.A., Opp M.R., and Krueger J.M. Somnogenic effects of rabbit and recombinant human interferons in rabbits. Am J Physiol 267 (1994) R53-R61
4. Sell K.M., Crowe S.F., and Kent S. Lipopolysaccharide induces memory-processing deficits in day-old chicks. Pharmacol Biochem Behav 68 (2001) 497-502
5. Swiergiel A.H., Smagin G.N., Johnson L.J., and Dunn A.J. The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: effects of acute and chronic administration of the interleukin-1-receptor antagonist (IL-1ra). Brain Res 776 (1997) 96-104
6. Gibertini M., Newton C., Friedman H., and Klein T.W. Spatial learning impairment in mice infected with Legionella pneumophila or administered exogenous interleukin-1-beta. Brain Behav Immun 9 (1995) 113-128
7. Larson S.J. Behavioral and motivational effects of immune-system activation. J Gen Psychol 129 (2002) 401-414
8. Kent S., Bluthe R.M., Kelley K.W., and Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol Sci 13 (1992) 24-28
9. Kotzin B.L. Systemic lupus erythematosus. Cell 85 (1996) 303-306
10. Sibley J.T., Olszynski W.P., Decoteau W.E., and Sundaram M.B. The incidence and prognosis of central nervous system disease in systemic lupus erythematosus. J Rheumatol 19 (1992) 47-52
11. Wong K.L., Woo E.K., Yu Y.L., and Wong R.W. Neurological manifestations of systemic lupus erythematosus: a prospective study. Quart J Med 81 (1991) 857-870
12. Boumpas D.T., Austin III H.A., Fessler B.J., Balow J.E., Klippel J.H., and Lockshin M.D. Systemic lupus erythematosus: emerging concepts. Part 1: renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann Intern Med 122 (1995) 940-950
13. West S.G. Neuropsychiatric lupus. Rheum Dis Clin N Am 20 (1994) 129-158
14. Carbotte R.M., Denburg S.D., and Denburg J.A. Cognitive dysfunction in systemic lupus erythematosus is independent of active disease. J Rheumatol 22 (1995) 863-867
15. Fisk J.D., Eastwood B., Sherwood G., and Hanly J.G. Patterns of cognitive impairment in patients with systemic lupus erythematosus. Br J Rheumatol 32 (1993) 458-462
16. Hay A.M., and Creed F. Psychiatric disorder and cognitive impairment in SLE. J Rheumatol 22 (1995) 2187
17. Lindal E., Thorlacius S., Steinsson K., and Stefansson J.G. Psychiatric disorders among subjects with systemic lupus erythematosus in an unselected population. Scand J Rheumatol 24 (1995) 346-351
18. Walker S.E., Wright D.C., O'Sullivan F.X., Johnson G.C., Besch-Williford C.L., and Vogelweid C.M. Memory, learning ability, and neuropathologic status of mice with systemic lupus erythematosus. Ann NY Acad Sci 823 (1997) 107-115
19. Ballok D.A., Woulfe J., Sur M., Cyr M., and Sakic B. Hippocampal damage in mouse and human forms of systemic autoimmune disease. Hippocampus 14 (2004) 649-661
20. Tomita M., Khan R.L., Blehm B.H., and Santoro T.J. The potential pathogenetic link between peripheral immune activation and the central innate immune response in neuropsychiatric systemic lupus erythematosus. Med Hypotheses 62 (2004) 325-335
21. Ali I.I., Savolaine E., Pirzada N., Tomita M., and Santoro T.J. Possible role of the hippocampus in the pathogenesis of cognitive dysfunction in neuropsychiatric systemic lupus erythematosus. Med Hypotheses Res 1 (2004) 111-119
22. Utset T.O., Golden M., Siberry G., Kiri N., Crum R.M., and Petri M. Depressive symptoms in patients with systemic lupus erythematosus: association with central nervous system lupus and Sjogren's syndrome. J Rheumatol 21 (1994) 2039-2045
23. Keenan P.A., and Conway J. Psychiatric and neurocognitive concomitants of systemic lupus erythematosus. Ann NY Acad Sci 823 (1997) 69-80
24. Sakic B., Szechtman H., Braciak T., Richards C., Gauldie J., and Denburg J.A. Reduced preference for sucrose in autoimmune mice: a possible role of interleukin-6. Brain Res Bull 44 (1997) 155-165
25. Sakic B., Szechtman H., Talangbayan H., Denburg S.D., Carbotte R.M., and Denburg J.A. Disturbed emotionality in autoimmune MRL-lpr mice. Physiol Behav 56 (1994) 609-617
26. Porsolt R.D., Le Pichon M., and Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 266 (1977) 730-732
27. Patterson P.H., and Nawa H. Neuronal differentiation factors/cytokines and synaptic plasticity. Cell 72 Suppl (1993) 123-137
28. Berninger B., and Poo M. Fast actions of neurotrophic factors. Curr Opin Neurobiol 6 (1996) 324-330
29. Larson S.J., and Dunn A.J. Behavioral effects of cytokines. Brain Behav Immun 15 (2001) 371-387
30. Merrill J.E. Proinflammatory and antiinflammatory cytokines in multiple sclerosis and central nervous system acquired immunodeficiency syndrome. J Immunother 12 (1992) 167-170
31. Bauer J., Strauss S., Schreiter-Gasser U., Ganter U., Schlegel P., Witt I., et al. Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett 285 (1991) 111-114
32. Klein B.D., White H.S., and Callahan K.S. Cytokine and intracellular signaling regulation of tissue factor expression in astrocytes. Neurochem Int 36 (2000) 441-449
33. Capuron L., Ravaud A., and Dantzer R. Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. J Clin Oncol 18 (2000) 2143-2151
34. Oitzl M.S., van Oers H., Schobitz B., and de Kloet E.R. Interleukin-1 beta, but not interleukin-6, impairs spatial navigation learning. Brain Res 613 (1993) 160-163
35. Schrott L.M., and Crnic L.S. Attenuation of behavioral abnormalities in autoimmune mice by chronic soluble interferon-gamma receptor treatment. Brain Behav Immun 12 (1998) 90-106
36. Combs C.K., Karlo J.C., Kao S.C., and Landreth G.E. beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci 21 (2001) 1179-1188
37. Watkins L.R., Maier S.F., and Goehler L.E. Cytokine-to-brain communication: a review and analysis of alternative mechanisms. Life Sci 57 (1995) 1011-1026
38. Banks W.A., Ortiz L., Plotkin S.R., and Kastin A.J. Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther 259 (1991) 988-996
39. Bluthe R.M., Michaud B., Kelley K.W., and Dantzer R. Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally. Neuroreport 7 (1996) 1485-1488
40. Bluthe R.M., Walter V., Parnet P., Laye S., Lestage J., Verrier D., et al. Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. CR Acad Sci III 317 (1994) 499-503
41. Lauwerys B.R., and Houssiau F.A. Cytokines: clues to the pathogenesis of SLE. Lupus 7 (1998) 211-213
42. Smolen J.S., Steiner G., and Aringer M. Anti-cytokine therapy in systemic lupus erythematosus. Lupus 14 (2005) 189-191
43. Tomita M., Holman B.J., and Santoro T.J. Aberrant cytokine gene expression in the hippocampus in murine systemic lupus erythematosus. Neurosci Lett 302 (2001) 129-132
44. Tomita M., Holman B.J., Williams L.S., Pang K.C., and Santoro T.J. Cerebellar dysfunction is associated with overexpression of proinflammatory cytokine genes in lupus. J Neurosci Res 64 (2001) 26-33
45. Aringer M., Feierl E., Steiner G., Stummvoll G.H., Hofler E., Steiner C.W., et al. Increased bioactive TNF in human systemic lupus erythematosus: associations with cell death. Lupus 11 (2002) 102-108
46. Schaefer M., Engelbrecht M.A., Gut O., Fiebich B.L., Bauer J., Schmidt F., et al. Interferon alpha (IFNalpha) and psychiatric syndromes: a review. Prog Neuropsychopharmacol Biol Psychiatry 26 (2002) 731-746
47. Aubert A. Sickness and behaviour in animals: a motivational perspective. Neurosci Biobehav Rev 23 (1999) 1029-1036
48. Aubert A., Kelley K.W., and Dantzer R. Differential effect of lipopolysaccharide on food hoarding behavior and food consumption in rats. Brain Behav Immun 11 (1997) 229-238
49. Hart B.L. Biological basis of the behavior of sick animals. Neurosci Biobehav Rev 12 (1988) 123-137
50. Miller N.E. Some psychophysiological studies of motivation and of the behavioural effects of illness. Bull Psychol Soc 17 (1964) 1-20
51. Baca V., Lavalle C., Garcia R., Catalan T., Sauceda J.M., Sanchez G., et al. Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus. J Rheumatol 26 (1999) 432-439
52. Ramos P.C., Mendez M.J., Ames P.R., Khamashta M.A., and Hughes G.R. Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus. Clin Exp Rheumatol 14 (1996) 295-299
53. Sun S.S., Huang W.S., Chen J.J., Chang C.P., Kao C.H., and Wang J.J. Evaluation of the effects of methylprednisolone pulse therapy in patients with systemic lupus erythematosus with brain involvement by Tc-99m HMPAO brain SPECT. Eur Radiol 14 (2004) 1311-1315
54. Hess D.C., Taormina M., Thompson J., Sethi K.D., Diamond B., Rao R., et al. Cognitive and neurologic deficits in the MRL/lpr mouse: a clinicopathologic study. J Rheumatol 20 (1993) 610-617
55. Sakic B., Szechtman H., Denburg J.A., Gorny G., Kolb B., and Whishaw I.Q. Progressive atrophy of pyramidal neuron dendrites in autoimmune MRL-lpr mice. J Neuroimmunol 87 (1998) 162-170
56. Ballok D.A., Millward J.M., and Sakic B. Neurodegeneration in autoimmune MRL-lpr mice as revealed by Fluoro Jade B staining. Brain Res 964 (2003) 200-210
57. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25 (1982) 1271-1277